1

2

3
Qing Tang, Wei Ping Wang, Zhongxue Gan, Ruiming Zhang, John Moh: Automatic vehicle following system. VI&T Group, McCormick Paulding & Huber, November 5, 1996: US05572449 (50 worldwide citation)

An automatic vehicle following system is provided for controlling a following vehicle to maintain at least a predetermined distance behind a preceding vehicle and to substantially follow the path of the preceding vehicle. An on-line measurement system of the preceding vehicle generates signals indic ...


4
Jingrong Cao, Jeremy Green, Michael Hale, Francois Maltais, Judy Straub, Qing Tang, Alex Aronov: Heterocyclic inhibitors of ERK2 and uses thereof. Vertex Pharmaceuticals Incorporated, Daniel A Pearson, August 7, 2007: US07253187 (42 worldwide citation)

Described herein are compounds that are useful as protein kinase inhibitors having the formula: wherein Z1 and Z2 are each independently nitrogen or CH and Ring A, TmR1, QR2, UnR3, and Sp are as described in the specification. The compounds are especially useful as inhibitors of ERK2 and for treatin ...


5

6
Qing Tang, Zhongxue Gan, Jeffrey Sherman Katz, Lance Terrance Fitzgibbons: Moving object tracking. Combustion Engineering, Alix Yale & Ristas, March 2, 1999: US05878151 (39 worldwide citation)

An image of the object remains in the field of view of the camera, thereby generating a continuously changing image signal. The images are captured and digitized in a continual sequence S of discrete images of the scenes at a respective sequence T of points in time. During this capture sequence, a f ...


7

8
Michael Robin Hale, Francois Maltais, Qing Tang, Judith Straub, Alexander Aronov: Heterocyclic inhibitors of ERK2 and uses thereof. Vertex Pharmaceuticals Incorporated, Daniel A Pearson, December 4, 2007: US07304061 (31 worldwide citation)

Described herein are compounds that are useful as protein kinase inhibitors having the formula: wherein A1, A2, TmR1, X, R2, R3, R9, R12, and R13 are as described in the specification. The compounds are especially useful as inhibitors of ERK2, Aurora2, GSK3, CDK2, AKT3, and ROCK protein kinases and ...


9
Michael Hale, Xiaoling Xie, Jeremy Green, Jingrong Cao, Christopher Baker, Francois Maltais, James Janetka, Guy Bemis, Michael Mullican, Judith Straub, Qing Tang, Robert Mashal: Pyrazole compositions useful as inhibitors of erk. Vertex Pharmaceuticals Incorporated, Karen E Brown, Vertex Pharmaceuticals Incorporated, June 6, 2006: US07056944 (29 worldwide citation)

Described herein are compounds that are useful as protein kinase inhibitors having the formula: where R1-4, Q, and T are described in the specification. The compounds are useful for treating disease states in mammals that are alleviated by a protein kinase inhibitor, particularly diseases such as ca ...


10
Michael Robin Hale, Francois Maltais, Qing Tang, Judith Straub, Alexander Aronov: Heterocyclic inhibitors of ERK2 and uses thereof. Vertex Pharmaceuticals Incorporated, Daniel A Pearson, March 18, 2008: US07345054 (26 worldwide citation)

Described herein are compounds that are useful as protein kinase inhibitors having the formula: wherein A1, A2, TmR1, X, R2, R3, R9, R12, and R13 are as described in the specification. The compounds are especially useful as inhibitors of ERK2, Aurora2, GSK3, CDK2, AKT3, and ROCK protein kinases and ...